Imodium N6

Loperamide Hydrochloride, the active ingredient in Imodium N6, is an opioid receptor agonist presented as an oral tablet for oral use. It treats acute nonspecific diarrhea and traveler’s diarrhea in adults and children over the recommended age. GNH USA supplies Imodium N6 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Loperamide Hydrochloride is used to manage diarrheal conditions that involve increased intestinal motility.

Acute nonspecific diarrhea: reduces stool frequency and liquidity, helping restore normal bowel function. Traveler's diarrhea: provides symptomatic relief and aids in maintaining hydration during short‑term travel‑related gastrointestinal upset.

Loperamide Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Constipation - Abdominal cramps or discomfort - Nausea - Dizziness - Dry mouth - Headache

Serious or Rare Side Effects: - Severe constipation leading to bowel obstruction - Toxic megacolon, especially in patients with underlying inflammatory bowel disease - Allergic reactions such as rash, urticaria, or angioedema - Cardiac arrhythmias, including QT interval prolongation - Severe abdominal pain or ileus - Hepatotoxicity in rare cases

Before using Imodium N6, consider the following safety measures.

Assess dehydration: ensure adequate fluid and electrolyte replacement prior to therapy. Avoid use in children under 2 years: contraindicated due to risk of severe side effects. Do not exceed recommended dose: follow prescriber or label instructions precisely. Use with caution in hepatic impairment: monitor for increased systemic exposure. Avoid concurrent use with strong CYP3A4 inhibitors: may raise plasma loperamide levels. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Loperamide can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increased risk of toxicity. - Other antidiarrheal agents (e.g., diphenoxylate, atropine): additive opioid effects. - QT‑prolonging drugs (e.g., quinidine, macrolide antibiotics): heightened risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics (e.g., erythromycin, clarithromycin): may raise loperamide concentrations. - Antihistamines or other constipating agents: monitor bowel habits for excessive slowing.